When Brigitte Boisselier held a press conference in the waning days of 2002 to announce that her controversial company, Clonaid, had come through on its promise to clone a human, you could almost hear the rumbling in Washington. (Bioworld Today)
When Brigitte Boisselier held a press conference in the waning days of 2002 to announce that her controversial company, Clonaid, had come through on its promise to clone a human, you could almost hear the rumbling in Washington. (Bioworld Today)
Scientists developing drugs for rare diseases will have a greater opportunity to win federal grants since President Bush signed legislation doubling funding for orphan product research. (BioWorld Today)
Scientists developing drugs for rare diseases will have a greater opportunity to win federal grants since President Bush signed legislation doubling funding for orphan product research. (BioWorld Today)
